Ponezumab Antibody
Ponezumab (PF-04360365) is a humanized IgG2 monoclonal antibody targeting amyloid-β. It has been shown in preclinical studies to reduce central nervous system Aβ levels and improve cognitive performance in mouse models, supporting its investigation for Alzheimer's disease research.
Product Specifications
Target
Beta Amyloid
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Neuroscience, Signal Transduction
Concentration
7.34 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.66 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC404061 20 µg
GCIP interacting protein p29 (SYF2) (NM_207170) Human Over-expression Lysate
Sign In for Pricing
View Details